Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases

Stopped Study terminated due to meeting interim analysis futility endpoint. No difference was found between two treatment arms at interim analysis of primary outcome.

Conditions

• Hematopoietic and Lymphoid Cell Neoplasm
• Non-Neoplastic Hematologic and Lymphocytic Disorder

Interventions

• OTHER: Supportive Palliative Care
• OTHER: Clinical Management
• OTHER: Best Practice
• PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
• OTHER: Questionnaire Administration
• OTHER: Quality-of-Life Assessment
• OTHER: Survey Administration

Sponsor

Fred Hutchinson Cancer Center

Collaborators

• National Cancer Institute (NCI)
• National Institutes of Health (NIH)